Log in to save to my catalogue

Methadone switching for refractory cancer pain

Methadone switching for refractory cancer pain

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f66edd9d559c4d21972713a6527072d8

Methadone switching for refractory cancer pain

About this item

Full title

Methadone switching for refractory cancer pain

Publisher

England: BioMed Central Ltd

Journal title

BMC palliative care, 2022-11, Vol.21 (1), p.191-7, Article 191

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Methadone is commonly considered an alternative opioid treatment for refractory cancer pain. This study aims to investigate the efficacy, safety, and cost of methadone in the treatment of refractory cancer pain.
A retrospective study was conducted in patients who used methadone for refractory cancer pain from April 2016 to December 2020 at a can...

Alternative Titles

Full title

Methadone switching for refractory cancer pain

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f66edd9d559c4d21972713a6527072d8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f66edd9d559c4d21972713a6527072d8

Other Identifiers

ISSN

1472-684X

E-ISSN

1472-684X

DOI

10.1186/s12904-022-01076-2

How to access this item